Procter & Gamble director of external relations Mark Chakravarty last week told an academic conference: ‘There is a high suspicion of the pharma industry. Greed, dishonesty and fraud are some of its associations.'
Chakravarty was responding to a week of bad publicity for the pharma industry, which saw GlaxoSmithKline criticised for allegedly hiding negative trial results concerning its anti-depressant Seroxat.
The publicity has prompted healthcare PROs to urge the industry to be more proactive in its communications.
Ash Communications director Carys Thomas Ampofo said: ‘A strong sustained campaign is required and not one based on reactive responses to [negative] stories.'
Ampofo's call for action was backed by Karen Winterhalter, partner at Onyx Health. She said: ‘The industry has to stop hiding away and starting positively promoting the good work it does.'